Product Information
METFORMIN HCL ER 750 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0542 per EA under NDC 67877041401. Its NADAC has been published 360 times since Oct 2, 2019.
FDA first approved this application on Oct 22, 2018. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877041401
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206145FDA Approved
10/22/2018
TE Code
AB1
On Market Since
10/27/2018
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL ER 750 MG TABLET has been published 360 times since Oct 2, 2019, and over the history we have for it it has declined 7.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0542 per EA |
|---|---|
| All-time high | $0.0942 (Feb 10, 2021) |
| All-time low | $0.0526 (Sep 17, 2025) |
| 52-week high | $0.0566 |
| 52-week low | $0.0526 |
| Median price | $0.0629 |
| Average price | $0.0671 |
| Largest weekly change | +26.5% (Dec 23, 2020) |
| Weeks tracked | 360 |
| Tracking since | Oct 2, 2019 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL ER 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL ER 750 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.0542 per EA (NDC 67877041401), effective Aug 19, 2026.
How has the price of METFORMIN HCL ER 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL ER 750 MG TABLET has declined 7.6%. It has been tracked across 360 weekly CMS publications since Oct 2, 2019.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL ER 750 MG TABLET?
Since Oct 2, 2019, the NADAC for METFORMIN HCL ER 750 MG TABLET has ranged from a low of $0.0526 (Sep 17, 2025) to a high of $0.0942 (Feb 10, 2021), with a median of $0.0629 per EA.
Are there cheaper alternatives to METFORMIN HCL ER 750 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL ER 750 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METFORMIN HCL ER 750 MG TABLET?
METFORMIN HCL ER 750 MG TABLET (NDC 67877041401) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.